Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × Photons × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Radiation Injuries 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Meningioma 1 Glioblastoma 1 Frailty 1 Esophageal Neoplasms 1 Breast Neoplasms 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Lung Neuroendocrine Tumor 1

Interventions

Cisplatin 80 Fluorouracil 66 Paclitaxel 62 Radiotherapy 56 Oxaliplatin 51 Irinotecan 35 Docetaxel 34 Leucovorin 32 Carboplatin 30 Capecitabine 26 Radiation 25 Surgical Procedures, Operative 20 pembrolizumab 17 Drug Therapy 15 Bevacizumab 15 Cetuximab 14 Nivolumab 12 tislelizumab 11 Chemoradiotherapy 11 Albumin-Bound Paclitaxel 10 camrelizumab 9 S 1 (combination) 9 Neoadjuvant Therapy 9 Esophagectomy 9 nimotuzumab 8 durvalumab 8 Trastuzumab 8 Radiotherapy, Intensity-Modulated 7 Gefitinib 7 nedaplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06408116 2026-03-10

PEGASUS

University Hospital Heidelberg

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡